DS1040b/Aspirin Drug/Drug Interaction Study


Phase 1 Results N/A

Summary of Purpose

This is a phase 1, open label, single dose study, after 5 days of aspirin treatment, in healthy male and female subjects. It is hypothesized that co-administering DS-1040b with aspirin at steady state will be safe and well tolerated by healthy male and female subjects.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 February 2014.

1 Jan 2014 21 Feb 2014 1 Feb 2014 1 Feb 2014 1 Feb 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Basic Science
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Single Group Assignment


Not available